| ISIN | LU1585229005 | 
|---|---|
| Valorennummer | |
| Bloomberg Global ID | |
| Fondsname | Bellevue Emerging Markets Healthcare I2 EUR | 
| Fondsanbieter | 
                                            
                                            
                                            Bellevue Asset Management AG
                                            
    
        Zürich, Schweiz Telefon: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch  | 
                                    
| Fondsanbieter | Bellevue Asset Management AG | 
| Vertreter in der Schweiz | 
                                            Waystone Fund Services (Switzerland) SA Lausanne Telefon: 0041213111781  | 
                                    
| Distributor(en) | 
                                            
                                                Bank am Bellevue AG Küsnacht Telefon: +41 44 267 67 67  | 
                                    
| Anlagekategorie | Aktienfonds | 
| EFC-Kategorie | |
| Anteilskategorie | Accumulation | 
| Domizilland | Luxemburg | 
| Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds | 
| Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds | 
| Investment-Strategie *** | The sub-fund is an equity fund. The investment objective of sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of emerging countries. | 
| Besonderheiten | 
| Aktueller Preis * | 138.36 EUR | 31.10.2025 | 
|---|---|---|
| Vorheriger Preis * | 136.79 EUR | 30.10.2025 | 
| 52 Wochen Hoch * | 145.19 EUR | 08.10.2025 | 
| 52 Wochen Tief * | 110.91 EUR | 09.04.2025 | 
| NAV * | 138.36 EUR | 31.10.2025 | 
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 75'073'796 | |
| Anteilsklassevermögen *** | ||
| Trading Information SIX | ||
| YTD-Performance | +9.66% | 
        30.12.2024 - 31.10.2025
        30.12.2024 31.10.2025  | 
                                    
|---|---|---|
| YTD-Performance (in CHF) | +8.83% | 
        30.12.2024 - 31.10.2025
        30.12.2024 31.10.2025  | 
                                        
| 1 Monat | -1.59% | 
        30.09.2025 - 31.10.2025
        30.09.2025 31.10.2025  | 
                                    
| 3 Monate | -2.76% | 
        31.07.2025 - 31.10.2025
        31.07.2025 31.10.2025  | 
                                    
| 6 Monate | +14.24% | 
        30.04.2025 - 31.10.2025
        30.04.2025 31.10.2025  | 
                                    
| 1 Jahr | +6.86% | 
        31.10.2024 - 31.10.2025
        31.10.2024 31.10.2025  | 
                                    
| 2 Jahre | -2.74% | 
        31.10.2023 - 31.10.2025
        31.10.2023 31.10.2025  | 
                                    
| 3 Jahre | -5.16% | 
        31.10.2022 - 31.10.2025
        31.10.2022 31.10.2025  | 
                                    
| 5 Jahre | -40.24% | 
        15.06.2021 - 31.10.2025
        15.06.2021 31.10.2025  | 
                                    
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BeOne Medicines Ltd Ordinary Shares | 6.74% | |
|---|---|---|
| Celltrion Inc | 6.29% | |
| WuXi Biologics (Cayman) Inc | 6.09% | |
| Sun Pharmaceuticals Industries Ltd | 5.55% | |
| Innovent Biologics Inc | 5.16% | |
| Akeso Inc Ordinary Shares | 4.39% | |
| Sino Biopharmaceutical Ltd | 4.30% | |
| Samsung BioLogics Co Ltd | 4.10% | |
| CSPC Pharmaceutical Group Ltd | 3.02% | |
| Cipla Ltd | 2.82% | |
| Letzte Daten-Aktualisierung | 30.09.2025 | |
| TER | 1.54% | 
|---|---|
| Datum TER | 29.01.2021 | 
| Performance Fee *** | 0.00% | 
| PTR | |
| Max. Management Fee *** | 0.90% | 
| Ongoing Charges *** | 1.41% | 
| 
                                            SRRI ***
                                             | 
                                    |
| Datum SRRI *** | 30.09.2025 |